Microbiome identification and bacteriophage formulations
US-2024123002-A1 · Apr 18, 2024 · US
Proteins used for the diagnosis of lyme borreliosis
US9977020B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9977020-B2 |
| Application number | US-201615019520-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 9, 2016 |
| Priority date | Aug 28, 2009 |
| Publication date | May 22, 2018 |
| Grant date | May 22, 2018 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Chimera proteins including: (i) at least one sequence of a DbpA protein of a Borrelia species selected from B. afzelii, B. burgdorferi sensu stricto and B. garinii , and (ii) at least one sequence of an OspC protein of a Borrelia species selected from B. afzelii, B. burgdorferi sensu stricto and B. garinii . Also, a method and a kit for the in vitro diagnosis of Lyme borreliosis using said proteins.
First claim
Opening claim text (preview).
The invention claimed is: 1. A chimeric polypeptide comprising (i) a first amino acid sequence comprising any of the amino acid sequences of SEQ ID Nos: 1, 3, 5 and 6, and (ii) a second amino acid sequence comprising any of the amino acid sequences of SEQ ID Nos: 2, 4 and 7. 2. The polypeptide as claimed in claim 1 , comprising the amino acid sequences of SEQ ID NO: 1 and SEQ ID NO: 2. 3. The polypeptide as claimed in claim 1 , comprising the amino acid sequences of SEQ ID NO: 1 and SEQ ID NO: 2. 4. The polypeptide as claimed in claim 1 , comprising the amino acid sequences of SEQ ID NO: 5 and SEQ ID NO: 7. 5. The polypeptide as claimed in claim 1 , comprising the amino acid sequences of SEQ ID NO: 6 and SEQ ID NO: 7. 6. The polypeptide as claimed in claim 1 , comprising the amino acid sequences of SEQ ID NO: 5, SEQ ID NO: 6, and SEQ ID NO: 7. 7. A diagnostic kit comprising the polypeptide as claimed in claim 1 . 8. The diagnostic kit as claimed in claim 7 , further comprising an anti-human-immunoglobulin labeled with a label. 9. The diagnostic kit as claimed in claim 7 , further comprising a chimeric Variable Lipoprotein Surface-Exposed (VlsE) polypeptide.
Assignees
Inventors
Classifications
Immunostimulants · CPC title
containing a tag for immunodetection, or an epitope for immunisation · CPC title
against anti-bacterial Ig · CPC title
- G01N33/56911Primary
Bacteria · CPC title
from bacteria · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9977020B2 cover?
- Chimera proteins including: (i) at least one sequence of a DbpA protein of a Borrelia species selected from B. afzelii, B. burgdorferi sensu stricto and B. garinii , and (ii) at least one sequence of an OspC protein of a Borrelia species selected from B. afzelii, B. burgdorferi sensu stricto and B. garinii . Also, a method and a kit for the in vitro diagnosis of Lyme borreliosis using…
- Who is the assignee on this patent?
- Biomerieux Sa
- What technology area does this patent fall under?
- Primary CPC classification G01N33/56911. Mapped technology areas include Physics.
- When was this patent published?
- Publication date Tue May 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).